Trevena to Participate in Upcoming Conferences in June 2019
May 29 2019 - 4:01PM
Trevena, Inc. (Nasdaq: TRVN), a biopharmaceutical
company focused on the development and commercialization of novel
medicines for patients affected by Central Nervous System
conditions, today announced that Carrie Bourdow, President and
Chief Executive Officer, and Mark Demitrack, SVP and Chief Medical
Officer, will present at two upcoming conferences:
- 2019 BIO International Convention, sponsored by the
Biotechnology Innovation Organization, to be held at the
Philadelphia Convention Center in Philadelphia, PA on Wednesday,
June 5, 2019 at 3:45pm ET. Live audio webcast and archived replay
of the presentation will be available on the Company’s investor
relations website at https://investors.trevena.com/. Following the
conclusion of the presentation, the webcast will be available for
replay for 30 days.
- JMP Securities Life Sciences Conference, sponsored by JMP
Securities, to be held at The St. Regis New York in New York City
on June 20, 2019 at 1:30pm ET.
For more information about the conferences, or to schedule a
one-on-one meeting with the Company’s management, please contact
KCSA Strategic Communications at Trevena@kcsa.com, or send an email
to biopartnering@bio.org (2019 BIO International Convention), or
kweisgerber@ljfevents.com (JMP Securities Life Sciences
Conference).
About TrevenaTrevena, Inc. is a
biopharmaceutical company focused on the development and
commercialization of novel medicines for patients affected by
Central Nervous System conditions. The Company has four novel
and differentiated investigational drug candidates, including IV
oliceridine, for the management of moderate to severe acute pain in
hospitals, TRV250 for the acute treatment of migraine, and TRV734
for maintenance treatment of opioid use disorder. The Company
has also identified TRV045, a novel S1P receptor modulator that may
offer a new, non-opioid approach to managing chronic pain.
For more information, please contact:
Investor Contact:Valter Pinto / Allison
SossKCSA Strategic CommunicationsPhone: 212-896-1254 /
212-896-1267Email: IR@trevena.com
Company Contact:Bob Yoder, SVP and Chief
Business OfficerTrevena, Inc.Phone: 610-354-8840
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From Apr 2024 to May 2024
Trevena (NASDAQ:TRVN)
Historical Stock Chart
From May 2023 to May 2024